High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome

(2011) Weihong Hu et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity

(2010) Thozhukat Sathyapalan et al.   MEDIATORS OF INFLAMMATION

Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome

(2010) Dong-Hyeon Lee et al.   Korean Circulation Journal

Evidence of proatherogenic inflammation in polycystic ovary syndrome

(2009) Frank González et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors

(2008) L. Alberti et al.   ATHEROSCLEROSIS

Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease

(2008) M. E. Suliman et al.   Clinical Journal of the American Society of Nephrology

Inflamed adipose tissue, insulin resistance and vascular injury

(2008) Christian X. Andersson et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions

(2008) AS Savchenko et al.   JOURNAL OF PATHOLOGY

Insulin resistance and polycystic ovary syndrome

(2008) Aldo Galluzzo et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

(2007) Satoshi Suzuki et al.   AMERICAN HEART JOURNAL

Prognostic value of pentraxin 3 in patients with chronic heart failure

(2007) Norihiko Kotooka et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY